Related Experiment Video
Updated: May 11, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
When is the use of aspirin for CVD prevention in women appropriate?
Joann E Manson1, Shari S Bassuk
1From the Brigham & Women_s Hospital, Harvard Medical School, Boston, MA.
Women age 65 and older without known cardiovascular disease (CVD), women of any age with established CVD, and women of any age with an estimated 10-year risk of CVD ≥10%, are likely to experience a net benefit from preventive low-dose aspirin therapy and should be considered for such therapy unless contraindicated.
Women age 65 and older without known cardiovascular disease (CVD), women of any age with established CVD, and women of any age with an estimated 10-year risk of CVD ≥10%, are likely to experience a net benefit from preventive low-dose aspirin therapy and should be considered for such therapy unless contraindicated.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
